Join us for our promotional symposium at the ARNS Conference 2025
Opportunities to act to help improve COPD patient care – Can we do more?

GSK has provided sponsorship monies used to purchase exhibition space and sponsored speaker sessions. GSK has had no input into the content of the programme or the choice of speakers with the exception of clearly marked GSK sponsored sessions.
This promotional symposium is intended for UK healthcare professionals and other relevant decision makers attending ARNS Conference 2025 only. GSK products will be mentioned at this symposium.
Why attend?
- Understand the challenges of managing your typical COPD patients and the impact of co-morbidities
- Discuss the current treatment goals for COPD
- Discover where we can be more ambitious in our patient care
Date: Thursday 15th May 2025
Time: 15:15 - 15:45 Main Session, 15:45 - 16:15 Q&A on the GSK Promotional Stand
Venue: Deansgate Suite, ARNS Conference 2025, Hilton Manchester Deansgate, M3 4LQ
Chair - Beverley Bostock
Beverley is an Advanced Nurse Practitioner in Gloucestershire and an independent prescriber. She is the Asthma Lead for ARNS, Chair of the ARNS Respiratory Diseases committee, and sits on the Executive Committee of the PCRS and Asthma and Lung UK's Council of Healthcare Professionals. She holds an MSc in Respiratory Care and an MA in Medical Ethics and Law. Bev was part of the NICE Asthma Quality Standards development and the National Review of Asthma Deaths. She is Editor in Chief of Practice Nurse Journal and has been a Queen’s Nurse since 2015.


Speaker - Jacqui Pollington
Jacqui Pollington became a registered general nurse in 1990. She holds a degree in Biosciences & Health and a Master’s in Advanced Nursing Practice. Her career spans clinical practice and service development in asthma, COPD, hospital- at- home exacerbation management, PR, home oxygen assessment, bronchiectasis, COVID virtual ward, and tobacco dependence. After working in Mid Yorks NHST until 2017, she moved to Barnsley and set up the community respiratory service. In 2019, she became the clinical lead for the South Yorkshire & Bassetlaw ICS QUIT programme. She currently chairs the BTS specialist advisory group on tobacco dependence.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to GSK on 0800 221 441 or uksafety@gsk.com.
March 2025 | NP-GB-CPU-WCNT-250011 (V1.0)